Hormones ,cytokines and fetal anomalies in habitual abortion

References

• Salat-Baroux J. Recurrent spontaneous abortions.Reprod Nutr Dev 1988;28:1555–68
   PubMedGoogle Scholar
• Clifford K, Rai R, Watson H, et al. An inform-ative protocol for the investigation of recurrent miscarriage; preliminary experience of 500 consecutive cases. Hum Reprod 1994;9:1328–32
   PubMed Web of Science ®Google Scholar
• Carp HJA. Pitfalls in interpreting therapy for early pregnancy. Early Pregnancy 1996;2:96–101
   PubMedGoogle Scholar
• Boue J, Boue A, Lazar P. The epidemiology of human spontaneous abortions with chromosomal anomalies. In Blandau RJ, ed. Aging Gametes. Basel: Karger, 1975:330
   Google Scholar
• Stein Z. Early fetal loss. Birth Defects 1981;17:95–9
   PubMedGoogle Scholar
• Ogasawara M, Aoki K, Okada S, et al. Embryonic karyotype of abortuses in relation to the number of previous miscarriages. Fertil Steril 2000;73: 300–4
   PubMed Web of Science ®Google Scholar
• Stern JJ, Dorfman AD, Gutierez-Najar MD, et al. Frequency of abnormal karyotyp es among abortuses from women with and without a history of recurrent spontaneous abortion. Fertil Steril 1996;65:250–3
   Google Scholar
• Carp HJA, Toder V, Orgad S, et al. Karyotype of the abortus in recurrent miscarriage. Fertil Steril 2001;5:678–82
   Google Scholar
• Royal College of Obstetricians and Gynaecol-ogists. The Management of Recurrent Miscarriage. Guideline No. 17. London: RCOG, 1998
   Google Scholar
• Blank M, Cohen J, Toder V, et al. Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polydonal anti-cardiolipin antibodies. Proc Natl Acad Sci USA 1991;88:3069–73
   PubMed Web of Science ®Google Scholar
• Bakimer R, Fishman P, Blank M, et al. Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3). J Clin Invest 1992;89:1558–63
   PubMed Web of Science ®Google Scholar
• Chavez DJ, McIntyre JA. Sera from women with histories of repeated pregnancy losses cause abnormalities in mouse perimplantation blasto-cysts. J Reprod Immunol 1984;6:273–81
   PubMed Web of Science ®Google Scholar
• OksenbergJR., Brautbar C. In vitro suppression of murine blastocysts growth by sera from women with reproductive disorders. Am J Reprod Immunol Microbiol 1986;11:118–24
   PubMed Web of Science ®Google Scholar
• Zigril M, Fein A, Carp HJA, et al. Immuno-potentiation reverses the embryotoxic effect of serum from women with pregnancy loss. Fertil Steril 1991;56:653–9
   PubMed Web of Science ®Google Scholar
• Abir R, Ornoy A, Ben Hur H, et al. The effects of sera from women with spontaneous abor-tions on the in vitro development of early somite stage rat embryos. Am J Reprod Immunol 1994; 32:73–81
   PubMed Web of Science ®Google Scholar
• Carp HJA, Toder V, Mashiach S, et al. Early pregnancy loss: current concepts of research and treatment. Obstet Gynecol Surv 1990;45:657–69
   PubMedGoogle Scholar
• Lindsay DJ, Lovett IS, Lyons EA, et al. Yolk sac diameter and shape at endovaginal US: predictors of pregnancy outcome in the first trimester. Radiology 1992;183:115–18
   PubMed Web of Science ®Google Scholar
• Greene MF, Hare JW, Cloherty JP, et al. First-trimester hemoglobin A1 and risk for major malformation and spontaneous abortion in diabetic pregnancy. Teratology 1989;39:225–31
   PubMedGoogle Scholar
• Reece EA, Homko CJ, Wu YK. Multifactorial basis of the syndrome of diabetic embryopathy. Teratology 1996;54:171–83
   Google Scholar
• Torchinsky A, Fein A, Carp HJA, et al. MHC associated immunopotentiation affects the embryo response to teratogens. Clin Exp Immunol 1994;98:513–19
   PubMed Web of Science ®Google Scholar
• Nomura T, Hata S, Kusafuka T. Suppression of developmental anomalies by maternal macro-phages in mice. J Exp Med 1990;172:1325–30
   Google Scholar
• Clark DA, Lea RG, Flanders KC, et al. Role of a unique species of TGF-I3 in preventing rejection of the conceptus during pregnancy. In Gergely J, Benczur M, Erdei N, eds. Progress in Immunology VIII. Budapest: Springer-Verlag, 1992:841–52
   Google Scholar
• Chaouat G, Menu E, Wegmann TG. Role of lymphokines of the CSF family and of TNF, gamma interferon and IL-2 in placental growth and fetal survival studied in two murine models of spontaneous resorptions. In Chaouat G, Mowbray JF, eds. Cellular and Molecular Biology of the Maternal—Fetal Relationship. Paris: INSERM/ John Libbey Eurotext, 1991:91
   Google Scholar
• Arck PC, Merali FS, Stanisz AM, et al. Stress-induced murine abortion associated with substance P-dependent alteration in cytokines in maternal uterine decidua. Biol Reprod 1995; 53:814–19
   PubMed Web of Science ®Google Scholar
• Wegmann TG. The cytokine basis for cross-talk between the maternal immune and reproductive systems. Curr Opin Immunol 1990;2:765–9
   Web of Science ®Google Scholar
• King A, Jo khi PP, Burrows TD, et al. Functions of human decidual NK cells. Am J Reprod Immunol 1996;35:258–60
   PubMed Web of Science ®Google Scholar
• Baines MG, Duglos AJ, de Fougerolles AR, et al. Immunological prevention of spontaneous early embryo resorption is mediated by non specific immunostimulation. Am J Reprod Immunol 1996; 35:34–42
   PubMed Web of Science ®Google Scholar
• Yui J, Garcia-Lloret M, Wegmann TG, et al. Cytotoxicity of tumor necrosis factor-alpha and gamma-interferon against primary human placental trophoblast. Placenta 1994;15:819–35
   PubMed Web of Science ®Google Scholar
• Gendron RL, Nestel FP, Lapp WS, et al. Lipo-polysaccharide-induced fetal resorption in mice is associated with the intrauterine production of tumor necrosis factor-alpha. J Reprod Fertil 1990;90:395–402
   PubMedGoogle Scholar
• Heyborne KD, Witkin SS, McGregor JA. Tumor necrosis factor-a in midtrimester amnniotic fluid is associated with impaired intrauterine fetal growth. Am J Obstet Gynecol 1992;167:920–5
   Google Scholar
• Arck PC, Troutt AB, Clark DA. Soluble receptors neutralizing TNF-a and IL-1 block stress-triggered murine abortion. Am J Reprod Immunol 1997;37: 262–6
   Google Scholar
• Bry K, Halman M. Transforming growth factor-beta 2 prevents preterm delivery induced by interleukin-1 alpha and tumor necrosis factor alpha in the rabbit. Am J Obstet Gynecol 1993; 168:1318–22
   PubMed Web of Science ®Google Scholar
• Beck TW, Magnuson NS, Rapp UR. Growth factor regulation of cell cycle progression and cell fate determination. Curr Top Microbiol Immunol 1995;194:291–303
   Google Scholar
• Force T, Bonventre JV. Growth factors and mito gen-activated protein kinases. Hypertension 1998;31:152–61
   PubMed Web of Science ®Google Scholar
• Knudsen TV. Cell death. In Kavlock RJ, Daston GP, eds. Drug Toxicity in Embryonic Development I. Berlin, Heidelberg, NewYork: Springer-Verlag, 1997:453–518
   Google Scholar
• Mirkes PE. Cellular responses to stress. In Kavlock RJ, Daston GP, eds. Drug Toxicity in Embryonic Development I. Berlin, Heidelberg, New York: Springer-Verlag, 1997:245–76
   Google Scholar
• Mirkes PE. Cyclophosphamide teratogenesis: a review. Teratogen Carcinogen Mutagen 1985;5: 75–88
   PubMedGoogle Scholar
• Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 1994;266:1821–8
   PubMed Web of Science ®Google Scholar
• Bursh W, Oberhammer F, Shulte-Herman R. Cell death by apoptosis and its protective role against disease. Trends Pharmacol Sci 1992;12: 245–51
   Google Scholar
• Jaskoll TH, Choy HA, Chen H, et al. Develop-mental expression and CORT-regulation of TGF-I3 and EGF receptor mRNA during mouse palatal morphogenesis: correlation between CORT-induced cleft palate and TGF-I32 mRNA expression. Teratology 1996;54:34 — 44
   PubMedGoogle Scholar
• Torchinsky A, Savion S, Gorivodsky M, et al. Cyclophosphamide-induced teratogenesis in ICR mice: the role of apoptosis. Teratogen Carcin-ogen Mutagen 1995;15:179–90
   PubMed Web of Science ®Google Scholar
• Ivnitsky I, Torchinsky A, Gorivodsky M, et al. TNF-a expression in embryos exposed to a teratogen. AmJ Reprod Immunol1998;40:431–40
   PubMed Web of Science ®Google Scholar
• Savion S, Brengauz-Breitmann M, To rchinsky A, et al. A possible role for granulocyte—macrophage colony stimulating factor in modulating teratogen-induced effects. Teratogen Carcinogen Mutagen 1999;19:171–82
   PubMedGoogle Scholar
• Wells PG, Kim PM, Nicol CJ, et al. Reactive intermediates. In Kavlock RJ, Daston GP, eds. Drug Toxicity in Embryonic Development I. Berlin, Heidelberg, NewYork: Springer-Verlag, 1997:453–518
   Google Scholar
• Morgan ET. Regulation of cyto chromes P450 during inflammation and infection. Drug Metab Rev 1997;29:1129–88
   PubMed Web of Science ®Google Scholar
• Chaouat G, Kiger N, Wegmann TG. Vaccination against spontaneous abortion in mice. J Reprod Immunol 1983;5:389–92
   Google Scholar
• Chaouat G, Menu E, Smedt D, et al. The emerging role of IL-10 in pregnancy. AmJ Reprod Immunol 1996;35:325–9
   PubMed Web of Science ®Google Scholar
• Edwards MJ, Shiota K, Smith MRS, et al. Hyper-thermia and birth defects. Reprod Toxicol 1995; 9:411–25
   PubMed Web of Science ®Google Scholar
• Yitzhakie D, Torchinsky A, Savion S, et al. Maternal immunopotentiation affects the terato-genic response to hypothermia. J Reprod Immunol 1999;45:49–66
   PubMed Web of Science ®Google Scholar
• Scialli AR. Is stress a developmental toxin? Reprod Toxicol 1988;1:163–72
   Google Scholar
• Clark DA, Banwatt D, Chaouat G. Stress-triggered abortion in mice is prevented by allo-immunization. Am J Reprod Immunol 1993;29: 141–7
   Google Scholar
• Torchinsky A, To der V, Savion S, et al. Immuno-potentiation increases the resistance of mouse embryos to diabetes induced teratogenic effect. Diabetologia 1997;40:635–40
   PubMed Web of Science ®Google Scholar
• Higuchi K, Aoki K, Kimbara T, et al. Suppression of natural killer cell activity by mono cytes follow-ing immunotherapy for recurrent spontaneous aborters. Am J Reprod Immunol 1995;33:221–7
   PubMed Web of Science ®Google Scholar
• Gafter U, Sredni B, Segal J, et al. Suppressed cell-mediated immunity and monocyte and natural killer cell activity following allogeneic immunization of women with spontaneous recurrent abortion. J Clin Immunol 1997;17: 408–19
   PubMed Web of Science ®Google Scholar
• Ruiz JE, Kwak JY, Baum L, et al. Intravenous immunoglobulin inhibits natural killer cell activity in vivo in women with recurrent spon-taneous abortion. Am J Reprod Immunol 1996; 35:370–5
   PubMed Web of Science ®Google Scholar
• Recurrent Miscarriage Immunotherapy Trialists Group. Worldwide collaborative observational study and metaanalysis on allogenic leucocyte immunotherapy for recurrent spontaneous abortion. Am J Reprod Immunol 1994;32:55–72
   PubMed Web of Science ®Google Scholar
• Carp HJA, Torchinsky A, Portuguese S, et al., and the Recurrent Miscarriage Immunotherapy Trialists Group. Paternal leucocyte immunization after five or more miscarriages. Hum Reprod 1997; 12:250–5
   Google Scholar
• Ober C, Karrison T, Odem RR, et al. Mononuclear-cell immunisation in prevention of recurrent miscarriages: a randomised trial. Lancet 1999;354:365–9
   PubMed Web of Science ®Google Scholar
• Carp HJA. Immunization with refrigerated pater-nal cells did not prevent recurrent miscarriage. Evidence Based Obstet Gynecol 2000;2:49
   Google Scholar
• Coulam CB. Immunotherapy for recurrent spon-taneous abortion. Early Pregnancy 1995;1:13–26
   PubMedGoogle Scholar
• Carp HJA, Ahiron R, Mashiach S, et al. Intra-venous immuno globulin in women with five or more abortions. Am J Reprod Immunol 1996; 35:360–2
   PubMed Web of Science ®Google Scholar
• Daya S, Gunby J. The effectiveness of allogeneic leucocyte immunization in unexplained primary recurrent spontaneous abortion. Am J Reprod Immunol 1994;32:294–302
   PubMed Web of Science ®Google Scholar
• Carp HJA, Toder V, Gazit E, et al. Further experience with intravenous immunoglobulin in women with recurrent miscarriage and a poor prognosis. Am J Reprod Immunol 2001; in press
   Google Scholar
• Vacca A, Martinotti S, Screpanti I, et al. Trans-criptional regulation of the interleukin 2 gene by glucocorticoid hormones. J Biol Chem 1990;265: 8075–80
   PubMed Web of Science ®Google Scholar
• Moynihan JA, Callahan T, Kelley SP, et al. Adre-nal hormone modulation of type 1 and 2 cytokine production by spleen cells: dexamethasone and dehydroepiandrosterone suppress interleukin-2, interleukin-4 and interferon-gamma production in vitro. Cell Immunol 1998;184:58–64
   PubMed Web of Science ®Google Scholar
• Daynes RA, Meikle AW, Araneo BA. Locally active steroid hormones may facilitate compart-mentalization ofimmunity by regulating the types of lymphokines produced by helper T cells. Res Immunol 1991;142:40–4
   Google Scholar
• Rooks, GAW, Hernandez-Pando R, Lightman SL. Hormones, peripherally activated prohorrn-ones and regulation of the Th1/Th2 balance. Immunol Today 1994;13: 301–3
   Google Scholar
• Culpepper J, Lee F. Regulation of IL-3 expression by glucocorticoids in cloned murine T-lymphocytes. J. Immunol 1985;135:3191–8
   PubMed Web of Science ®Google Scholar
• Visser J, van Boxel-Dezaire A, Methorst D, et al. Differential regulation of interleukin 10 (IL10) and IL-12 by glucocorticoids in vitro. Blood 1998; 91:4255–64
   Google Scholar
• Braun CM, Huang SK, Bashian GG, et al. Corticosteroid modulation of human antigen-specific Th1 and Th2 responses. J Allergy Clin Immunol 1997;100:400–7
   PubMed Web of Science ®Google Scholar
• White, A, Wang MW, King IS, et al. Biotinylated anti-progesterone monoclonal antibodies specifi-cally target the uterine epithelium and block implantation in the mouse. J Reprod Immunol 1992;21:127–38
   PubMed Web of Science ®Google Scholar
• Chaouat G, Menu R, Kinski R, et al. Immuno-regulatory role of the placenta. J Immunol Immuno-pharmacol 1990;10:45–50
   Google Scholar
• Szekeres-Bartho J. In Immunosuppression by Progesterone in Pregnancy. Boca Raton, FL: CRC Press, 1992:456–71
   Google Scholar
• Piccinni MP, Scaletti C, Maggi E, et al. Role of hormone-controlled Th1- and Th2-type cyto-kines in successful pregnancy. J Neuroimmunol 2000;109:30–3
   PubMed Web of Science ®Google Scholar
• Parronchi P, Macchia D, Piccinni, MP, et al. Allergen and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc Natl Acad Sci USA 1991;88:4538–42
   PubMed Web of Science ®Google Scholar
• Maggi E, Parronchi P, Manetti R, et al. Recipro-cal regulatory role of IFN-y and IL-4 on the in vitro development of human Th1 and Th2 cells. J Immunol 1992;148:2142–7
   PubMed Web of Science ®Google Scholar
• Piccinni MP, Giudizi MG, Biagiotti R, et al. Progesterone favors the development ofhuman T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established ThI cells clones. J Immunol 1995;155:128–33
   PubMed Web of Science ®Google Scholar
• Huber SA, Kupperrnan J, Newell MK. Estradiol prevents and testosterone promotes Fas-dependent apoptosis in CD4+ Th2 cells by altering Bc12 expression. Lupus 1999;8: 384–7
   Google Scholar
• Sherwood OD. Relaxin. In Knobil E, Neill E, eds The Physiology of Reproduction, 2nd edn. New York: Raven Press, 861–1010
   Google Scholar
• Piccinni MP, Bani D, Beloni L. et al. Relaxin favors the development of activated human T cells into Th1-like effectors. EurJ Immunol 1999; 29:2241–7
   Google Scholar
• Hu SK, Mitcho YL, Rath NC. Effect of estradiol on interleukin-1 synthesis by macrophages. Int J Immunopharmacol 1988;10: 247–52
   Google Scholar
• Polan ML, Daniele A, Kuo A. Gonadal steroids modulate human mono cyte interleukin-1 (IL-1) activity. Fertil Steril 1988;49: 964–8
   Google Scholar
• Stock JL, Coderre JA, McDonald B, et al. Effects of estrogen in vivo and in vitro on spontaneous interleukin-1 release by monocytes from post-menop aus al wo men. J Clin Endocrinol Metab 1989; 68:364–8
   PubMed Web of Science ®Google Scholar
• Garcia-Lloret MI, Morrish DW, Wegmann TG, et al. Demonstration of functional cytokine—placental interactions: CSF-1 and GM-CSF stimulate human cytotrophoblast differentiation and peptide hormone secretion. Exp Cell Res 1994;214: 46–54
   Google Scholar
• Seki H, Zosmer A, Elder MG, et al. The regula-tion of progesterone and hCG production from placental cells by interleukin-1beta. Biochim Biophys Acta 1997;1336:342–8
   PubMed Web of Science ®Google Scholar
• Yanushpolsky EH, Ozturk M, Katalin P, et al. The effects of cytokines on human chorionic gonadotropin (hCG) production by a trophoblast cell line. J Reprod Immunol 1993;25:235–47
   PubMed Web of Science ®Google Scholar
• Matsuzaki N, Neki R, SawaiK, et al. Soluble IL-6 (IL-6) receptor in the sera of pregnant women forms a complex with IL6 and augments human chorionic gonadotropin production by normal human trophoblast through binding to the IL-6 signal transducer. J Clin Endocrinol Metab 1995; 80:2912–17
   PubMed Web of Science ®Google Scholar
• Fazleabas AT, Donnelly KM, Fortman JD, et al. Modulation of the baboon (Papio anubis) endo-metrium by chorionic gonadotropin (CG) during the period of uterine receptivity. Biol Reprod 1997;56(Suppl 1):176
   Google Scholar
• Bonduelle ML, Dodd R, Liabaers I, et al. Chorionic gonadotropin-beta rriRNA, a tropho-blast marker, is expressed in human 8-cell embryos derived from tripronucleate zygotes. Hum Reprod 1988;3:909–14
   PubMed Web of Science ®Google Scholar
• Han SW, Lei ZM, Rao CV. Up-regulation of cydooxygenase-2 gene expression by chronic gonadotropin during the differentiation of human endometrial stromal cells into decidua. Endocrinology 1996;137: 1791–7
   Google Scholar
• Chatterjee A, Jana NR, Bhattacharya S. Stimu-lation of cyclic AMP, 1713 oestradiol and protein synthesis by human chorionic gonadotropin in human endometrial cells. Hum Reprod 1997;12: 1903–8
   Google Scholar
• Uzumcu M, Coskun S, Jaroudi K, et al. Effect of human chorionic gonadotropin on cytokine production from human endometrial cells in vitro. Am J Reprod Immunol 1998;40:83–8
   PubMed Web of Science ®Google Scholar
• Schafer A, Pauli G, Friedmann W, et al. Human chorionic gonadotropin (hCG) and placental lactogen (hPL) inhibit interleukin-2 and increase interleukin-1I3 (IL-1I3) -6 (IL-6) and tumor necrosis factor (TNFa) expression monocyte cultures. J Perinat Med 1992;20:233–40
   PubMed Web of Science ®Google Scholar
• Jones GES. The luteal phase defect. Fertil Steril 1976;27:351–6
   PubMed Web of Science ®Google Scholar
• Csapo AT, Pulkkinen MO. Indispensability of the human corpus luteum in the maintenance of early pregnancy: lutectomy evidence. Obstet Gynecol Surv 1978;3:69–81
   Google Scholar
• Spitz IM, Bardin W, Benton L, et al. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 1998;338:1241–7
   PubMed Web of Science ®Google Scholar
• Balasch J, Vanrell J, Marquez M, et al. Dehydrogestone versus vaginal progesterone in the treatment of the endometrial luteal phase deficiency. Fertil Steril 1982;37:751–4
   PubMed Web of Science ®Google Scholar
• Reijnders FJ, Thomas CM, Doesburg WM, et al. Endocrine effects of 17 alpha-hydroxyprogest-ero ne caproate during early pregnancy: a double-blind clinical trial. Br J Obstet Gynaecol 1988;95:462–8
   PubMedGoogle Scholar
• Huang K. The primary treatment of luteal phase inadequacy: progesterone versus clomiphene citrate. Am J Obstet Gynecol 1986;155:824–8
   PubMed Web of Science ®Google Scholar
• Murray D, Reich L, Adashi E. Oral clomiphene citrate and vaginal progesterone suppositories in the treatment of luteal phase dysfunction: a comparative study. Fertil Steril 1989;51:35–41
   Google Scholar
• Wentz A, Herbert C, Maxson W, et al. Outcome of progesterone treatment of luteal phase inadequacy. Fertil Steril 1984;41:856–62
   PubMed Web of Science ®Google Scholar
• Daya S. Efficacy of progesterone support for pregnancy in women with recurrent miscarriage. A meta-analysis of controlled trials. Br J Obstet Gynaecol 1989;96:275–80
   PubMedGoogle Scholar
• Sadler SW, Baillie P. The use of human chorionic gonadotropin in recurrent abortion. S Aft Med J 1979;19:832–5
   Google Scholar
• Svigos J. Preliminary experience with the use of human chorionic gonadotrophin therapy in women with repeated abortion. Clin Reprod Fertil 1982;1:131–5
   PubMedGoogle Scholar
• Harrison RF. Treatment of habitual abortion with human chorionic gonadotropin: results of open and placebo-controlled studies. EurJ Obstet Gynecol Reprod Biol 1985;20:159–68
   PubMed Web of Science ®Google Scholar
• Harrison RF. Human chorionic gonado-trophin (hCG) in the management of recurrent abortion; results of a multi-centre placebo-controlled study. Eur J Obstet Gynecol Reprod Biol 1992;47:175–9
   PubMed Web of Science ®Google Scholar
• Quenby S, Farquharson RG. Human chorionic go nadotropin supplementation in recurring pregnancy loss: a controlled trial. Fertil Steril 1994;62:708–10
   PubMed Web of Science ®Google Scholar
• Achiron R, Tadmor 0, Mashiach S. Heart rate as a predictor of first trimester spontaneous abortion after ultrasound proven viability. Obstet Gynecol 1991;78:330–4
   Google Scholar